In support of this hypothesis, cells stably over-expressing PDHK4 exhibited an increase in KRAS activity and 3D cell growth in vitro and in vivo, suggesting a role for PDHK4 in the growth of KRAS mutant tumours. The gene discussed is KRAS; the disease is neoplasm.